Category: SeaPRwire

The First in China! BLA Submitted for Luzhu Biotech’s Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026

Hongkong – February 11, 2025 – (SeaPRwire) – On Feb. 9, 2025, the official website of the Center for Drug Evaluation, National Medical Products Administration of China indicates that the Biologics License Application (BLA) for Luzhu Biotech’s (2480.HK) biological product for prophylaxis, Recombinant Herpes Zoster

More